Advertisement
Screener

Inhibitor Therapeutics, Inc. (INTI) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested

1.7 / 5 stars · 17/50 Roast Me

Inhibitor Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested

Inhibitor Therapeutics, Inc. (INTI) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested of $0 as of 2020-12-31, per its 10-K filed 2021-03-26.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested · last filed 2021-03-26

  • 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested $0.00.
  • 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested $1.26K.
  • 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested $0.00.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested
2020-12-31$0.00
10-K · filed 2021-03-26
2019-12-31$1.26K
10-K · filed 2020-03-30
2018-12-31$0.00
10-K · filed 2019-03-07